Literature DB >> 29337067

The impact of growth factors on human induced pluripotent stem cells differentiation into cardiomyocytes.

Marianne E Yassa1, Iman A Mansour2, Nadia I Sewelam2, Hala Hamza3, Taghrid Gaafar2.   

Abstract

Human induced pluripotent stem cells (hiPSCs) act as a promising therapeutic alternative for cardiovascular diseases. They yield a large number of functional cardiomyocytes (CMs) from autologous cell sources without ethical or immunological problems. However, significant limitations still remain in terms of line-to-line variability in CM yield and reproducibility. AIM: To efficiently enhance NP0040 hiPSCs differentiation into CMs. MAIN
METHODS: Following a standard cardiac differentiation protocol using small molecules targeting the canonical Wnt signaling, growth factors (BMP4 and FGF2) and ascorbic acid were added further in order to increase the cardiac differentiation efficiency. All cultures were conducted in serum-free, feeder-free monolayer system followed by lactate purification. KEY
FINDINGS: Using NP0040 hiPSCs, the CM yield resulting from modulation of the Wnt signaling pathway alone was inefficient compared to previous studies while the addition of BMP4, FGF2 and ascorbic acid resulted in enhanced cardiac differentiation outcome. The later resulted in a high yield (up to 92%) of cardiac troponin-T (cTnT) + CMs contracting spontaneously as organized sheets in 15 independent experiments. They were validated structurally and functionally using immunofluorescent staining for sarcomeric α-actinin, cTnT, MLC2v and Connexin 43. Reverse-transcriptase PCR revealed cardiac transcription factors and cardiac-specific genes expression. CMs were electrically connected to one another. Recorded action potential (AP) showed waves of relatively mature ventricular-like phenotype. SIGNIFICANCE: We demonstrated that hiPSC lines respond differently to a standard cardiac differentiation protocol and that a well-orchestrated interplay between Wnt, BMP4, FGF/MEK and Ascorbic acid MEK/ERK1/2 signaling pathways is beneficial in enhancing the differentiation outcome.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ascorbic acid; BMP-4; Cardiac differentiation; Cardiomyocytes; FGF-2; Human induced pluripotent stem cells; Lactate enrichment; Wnt signaling

Mesh:

Substances:

Year:  2018        PMID: 29337067     DOI: 10.1016/j.lfs.2018.01.009

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

1.  Induced pluripotent stem cells derived cardiomyocytes from Duchenne Muscular Dystrophy patients in vitro.

Authors:  Fareeha Faizan Ghori; Mohsin Wahid
Journal:  Pak J Med Sci       Date:  2021 Sep-Oct       Impact factor: 1.088

2.  Physical stimulation by REAC and BMP4/WNT-1 inhibitor synergistically enhance cardiogenic commitment in iPSCs.

Authors:  Valentina Basoli; Sara Santaniello; Salvatore Rinaldi; Vania Fontani; Gianfranco Pigliaru; Matthias Wieser; Agata Strajeriu; Alessandro Castagna; Heinz Redl; Carlo Ventura; Regina Grillari; Margherita Maioli
Journal:  PLoS One       Date:  2019-01-23       Impact factor: 3.240

3.  Wnt signalling mediates miR-133a nuclear re-localization for the transcriptional control of Dnmt3b in cardiac cells.

Authors:  Vittoria Di Mauro; Silvia Crasto; Federico Simone Colombo; Elisa Di Pasquale; Daniele Catalucci
Journal:  Sci Rep       Date:  2019-06-27       Impact factor: 4.379

Review 4.  Human Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic Cardiomyopathies.

Authors:  Andreas Brodehl; Hans Ebbinghaus; Marcus-André Deutsch; Jan Gummert; Anna Gärtner; Sandra Ratnavadivel; Hendrik Milting
Journal:  Int J Mol Sci       Date:  2019-09-06       Impact factor: 5.923

5.  MiR-499 Responsive Lethal Construct for Removal of Human Embryonic Stem Cells after Cardiac Differentiation.

Authors:  Edan Elovic; Sharon Etzion; Smadar Cohen
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

Review 6.  Maturation strategies and limitations of induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Peng Wu; Gang Deng; Xiyalatu Sai; Huiming Guo; Huanlei Huang; Ping Zhu
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

Review 7.  Preconditioned and Genetically Modified Stem Cells for Myocardial Infarction Treatment.

Authors:  Kamila Raziyeva; Aiganym Smagulova; Yevgeniy Kim; Saltanat Smagul; Ayan Nurkesh; Arman Saparov
Journal:  Int J Mol Sci       Date:  2020-10-02       Impact factor: 5.923

Review 8.  Human Induced Pluripotent Stem Cell as a Disease Modeling and Drug Development Platform-A Cardiac Perspective.

Authors:  Mohamed M Bekhite; P Christian Schulze
Journal:  Cells       Date:  2021-12-09       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.